Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Macrogenics (NQ: MGNX )

5.590 -0.330 (-5.57%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 571,166
Open 5.700
Bid (Size) 5.460 (5)
Ask (Size) 5.710 (2)
Prev. Close 5.920
Today's Range 5.470 - 5.950
52wk Range 2.130 - 12.32
Shares Outstanding 61,107,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Latest Analyst Ratings for Macrogenics
 
Via Benzinga
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga

Performance

YTD
-12.11%
-12.11%
1 Month
-9.11%
-9.11%
3 Month
-5.57%
-5.57%
6 Month
+27.33%
+27.33%
1 Year
-49.18%
-49.18%

More News

Read More
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From MacroGenics, Inc.
Via Globe NewsWire
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
From MacroGenics, Inc.
Via Globe NewsWire
7 Analysts Have This to Say About Macrogenics
Via Benzinga
Expert Ratings for Macrogenics
Via Benzinga
What 7 Analyst Ratings Have To Say About Macrogenics
Via Benzinga
Where Macrogenics Stands With Analysts
Via Benzinga
$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%
Via Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
Via Benzinga
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
Via Investor's Business Daily
Dow Jumps Over 300 Points; S&P 500 Rises 1%
Via Benzinga
Why Shares of MacroGenics Were Dropping Tuesday
Via The Motley Fool
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
US Stocks Open Higher As Dow Surges 250 Points
Via Benzinga
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
Via Benzinga
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
From MacroGenics, Inc.
Via Globe NewsWire
Why MacroGenics Stock Crushed the Market on Monday
Via The Motley Fool
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences
Via Benzinga
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.